Biograil is working towards replacing needle injections of medicine with oral capsules instead, that will make everyday life significantly easier.
2021 is starting out on a good note for Biograil, who in collaboration with Innvite has obtained the first Innobooster grant from the Innovations Fund. The target group is people, who are living with the daily injections of medicine. E.g., because they have a lifelong necessity for growth hormone or insulin treatment. The way the capsule works, is by injecting the medicine directly into the stomach wall from a small “hook”, while the technology ensures optimal utilization of the active substances from the capsule.
In addition to removing nuisance from millions of patients worldwide, the Innobooster project will also mean:
- Increased safety, as more than one million injuries are reported in Europe every year caused by needle injections.
- Significant cost reduction in healthcare from lower expenses for treatment of patients.
- Environmental benefits by replacing the needle with material, that is fully biodegradable in nature.
Not surprisingly, many patients will prefer to swallow a capsule rather than an injection with a needle, and with Biograil, they can look forward to giving the skin some well-deserved rest.